Stock market announcement archive

Lifecare ASA: Ex. consolidation (reverse split) of shares and warrants today

October 1, 2024
Reference is made to the stock exchange announcement made on 27 September 2024 with key information regarding the consolidation (reverse split) of the Company’s shares and the warrants issued by the Company pursuant to a resolution made by the extraordinary general meeting held on 16 May 2024 (the “Warrants”). The following information is provided in […]
Read more

Lifecare ASA: Share consolidation (reverse split) and change of par value

September 30, 2024
Reference is made to the extraordinary general meeting in Lifecare ASA (the “Company”) held on 17 September 2024, where it was resolved to carry out a share consolidation (reverse split) in the ratio of 13:1. The share consolidation has now been registered with the Norwegian Register of Business Enterprises, and the Company’s share capital is […]
Read more

Lifecare ASA: Key information relating to the consolidation (reverse split) of shares and warrants and change of ISIN for the shares

September 27, 2024
Reference is made to the extraordinary general meeting of the Company held on 17 September 2024, where it was resolved to consolidate the Company’s shares. Reference is further made to the warrants issued by the Company pursuant to a resolution by the extraordinary general meeting of the Company held on 16 May 2024 (the “Warrants”). […]
Read more

Minutes from Extraordinary General Meeting

September 17, 2024
The Extraordinary General Meeting of Lifecare ASA was convened as a hybrid meeting on 17 September 2024. All proposals on the agenda were adopted, cf. the notification of the Extraordinary General Meeting that was published on Oslo Stock Exchange on 3 September 2024. The complete minutes of the Extraordinary General Meeting are attached and will […]
Read more

LIFECARE ASA: Extraordinary General Meeting

September 3, 2024
Lifecare ASA, a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), will hold an Extraordinary General Meeting 17 September 2024, at 09:00 (CEST). For the planned uplisting from Euronext Growth Oslo to Oslo Børs, a share consolidation is required to meet the NOK 10 per share listing requirement. Additionally, to […]
Read more

Lifecare ASA Q2 2024 presentation

August 22, 2024
Lifecare ASA will release its second quarter 2024 results on Tuesday 27 august 2024 at 07:00 a.m. CEST. The same day at 12:00 CEST, CEO Joacim Holter will present the results live at Carnegie AS, Fjordalleen 16, Aker Brygge in Oslo. After the presentation, Lifecare invites to 1:1 session with the CEO and the CFO. […]
Read more

LIFE – Successfully completed nine weeks of longevity trials

August 21, 2024
Bergen, Norway, 21 August 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), can announce positive results from nine weeks of sensor longevity trials. Reference is made to press releases 18 June 2024 when the company initiated the trials with wireless readout. The Sencell sensor […]
Read more